Q4 2019 13F Holders as of 31 Dec 2019
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
84,733,230
-
Total 13F shares
-
11,616,437
-
Share change
-
+540,672
-
Total reported value
-
$127,772,633
-
Price per share
-
$11.00
-
Number of holders
-
64
-
Value change
-
+$7,088,075
-
Number of buys
-
36
-
Number of sells
-
15
Institutional Holders of SUTRO BIOPHARMA, INC. - Common Stock, par value $0.001 per share (STRO) as of Q4 2019
As of 31 Dec 2019,
SUTRO BIOPHARMA, INC. - Common Stock, par value $0.001 per share (STRO) was held by
64 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
11,616,437 shares.
The largest 10 holders included
SV Health Investors, LLC, CITADEL ADVISORS LLC, EVENTIDE ASSET MANAGEMENT, LLC, Samsara BioCapital, LLC, VV Manager LLC, BlackRock Inc., Tekla Capital Management LLC, Camber Capital Management LP, BVF INC/IL, and VANGUARD GROUP INC.
This page lists
64
institutional shareholders reporting positions in this security
for the Q4 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.